📰 Column Group News
Page 5 - Column Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Column Group. Real-time updates on events, politics, business and more.
May 31, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
May 30, 2023
Citizens’ Financial Group’s CEO weighs in on how the regional bank is braving the banking crisis and beyond.
April 20, 2023
Press Release Circle Pharma announced today that two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting held April 14-19, in Orlando, Florida, highlight promising pre-clinical data of its first-in-class orally bioavailable macrocyclic…
March 25, 2023
RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Rating) – Investment analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for shares of RAPT Therapeutics in a research note issued on Tuesday, March 21st. HC Wainwright analyst R. Selvaraju expects that the company will earn ($0.88) per share for the quarter. HC Wainwright currently […]
March 24, 2023
HC Wainwright reiterated their buy rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Get Rating) in a report published on Tuesday, Benzinga reports. They currently have a $43.00 price target on the stock. HC Wainwright also issued estimates for RAPT Therapeutics’ Q1 2024 earnings at ($0.88) EPS, Q2 2024 earnings at ($0.91) EPS, Q3 2024 […]
March 24, 2023
HC Wainwright restated their buy rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Get Rating) in a research note released on Tuesday, Benzinga reports. The brokerage currently has a $43.00 price target on the stock. HC Wainwright also issued estimates for RAPT Therapeutics’ Q1 2024 earnings at ($0.88) EPS, Q2 2024 earnings at ($0.91) EPS, […]
February 13, 2023
Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome raises $77.3M in funding.
February 1, 2023
AviadoBio, a pioneering, pre-clinical stage gene therapy company focused on developing and delivering transformative medicines for people with neurodegenerative disorders, today announced the appointment
January 10, 2023
The Fintel Insider Sentiment quant model identifies US stocks that have experienced significant insider buying activity over the last 90 days.
December 3, 2022
Research analysts at The Goldman Sachs Group began coverage on shares of RAPT Therapeutics (NASDAQ:RAPT – Get Rating) in a research report issued to clients and investors on Thursday, The Fly reports. The firm set a “buy” rating and a $27.00 price target on the stock. The Goldman Sachs Group’s price target would indicate a […]